Design, synthesis and activity against human cytomegalovirus of non-phosphorylatable analogs of toyocamycin, sangivamycin and thiosangivamycin
dc.contributor.author | Renau, Thomas E. | en_US |
dc.contributor.author | Ludwig, Mary S. | en_US |
dc.contributor.author | Drach, John C. | en_US |
dc.contributor.author | Townsend, Leroy B. | en_US |
dc.date.accessioned | 2006-04-10T14:59:24Z | |
dc.date.available | 2006-04-10T14:59:24Z | |
dc.date.issued | 1992-12 | en_US |
dc.identifier.citation | Renau, Thomas E., Ludwig, Mary S., Drach, John C., Townsend,, Leroy B. (1992/12)."Design, synthesis and activity against human cytomegalovirus of non-phosphorylatable analogs of toyocamycin, sangivamycin and thiosangivamycin." Bioorganic & Medicinal Chemistry Letters 2(12): 1755-1760. <http://hdl.handle.net/2027.42/29717> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6TF9-42M846V-8C/2/69cc0e0bd607fafff6f3974050696944 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/29717 | |
dc.description.abstract | A number of 7-alkyl 4-aminopyrrolo[2,3-pyrimidine derivatives related to toyocamycin, sangivamycin and thiosangivamycin have been prepared and tested for their activity against human cytomegalovirus (HCMV). Only the thioamide substituted derivatives demonstrated biological activity. | en_US |
dc.format.extent | 364190 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Design, synthesis and activity against human cytomegalovirus of non-phosphorylatable analogs of toyocamycin, sangivamycin and thiosangivamycin | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbsecondlevel | Chemical Engineering | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Engineering | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Interdepartamental Program in Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109-1065 U.S.A. | en_US |
dc.contributor.affiliationum | Department of Biologic and Material Sciences, School of Dentistry, University of Michigan, Ann Arbor, Michigan 48109-1065 U.S.A. | en_US |
dc.contributor.affiliationum | Department of Biologic and Material Sciences, School of Dentistry, University of Michigan, Ann Arbor, Michigan 48109-1065 U.S.A. | en_US |
dc.contributor.affiliationum | Department of Chemistry, College of Literature, Arts and Sciences, University of Michigan, Ann Arbor, Michigan 48109-1065 U.S.A.; Interdepartamental Program in Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109-1065 U.S.A. | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/29717/1/0000051.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/S0960-894X(00)80470-9 | en_US |
dc.identifier.source | Bioorganic & Medicinal Chemistry Letters | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.